Browsing by 저자 : Narikazu Boku
전체 결과 7건 중 1-7 번을 표시중입니다.
-
1
Article
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
강윤구
;
유민희
;
Do?Youn Oh
;
et al
2020
-
2
Article
Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials
Yoon-Koo Kang
;
Martin Reck
;
Paul Nghiem
;
et al
2022
-
3
Article
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study
Yoon-Koo Kang
;
Satoshi Morita
;
Taroh Satoh
;
et al
2022
-
4
Article
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
· Li?Tzong Chen
;
· Li?Yuan Bai1
;
· Taihei Nishiyama
;
et al
2021
-
5
Article
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
Yoon-Koo Kang
;
Li-Tzong Chen
;
Min-Hee Ryu
;
et al
2022
-
6
Article
Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100
유민희
;
Alina S Muntean
;
Antonio Cubillo Gracian
;
et al
2021
-
7
Article
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial
강윤구
;
유민희
;
Hideo Baba
;
et al
2020